Login or Sign Up
15:59 Feb 06
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd. News And Announcements
Concord Biotech Ltd.
Industry Biotechnology
15:59 Feb 06
Quality
64/100
High Financial Strength
Valuation
26/100
Expensive Valuation
Technical
36/100
Technically Neutral
Strength
0
Weakness
0
Opportunity
0
Threats
0
13.88K
Market Cap (Cr)
-
PE Ratio
7.60
Price to Book Ratio
RSI
30.96 %
Net Profit Margin
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully